Sponsor: Bristol-Myers Squibb (industry)
Phase: 2/3
Start date: Dec. 31, 2025
Planned enrollment: 990
BNT327 (also known as PM8002) is an investigational bispecific antibody that targets PD‑L1 and VEGF‑A. It originated at Biotheus and is now being advanced globally by BioNTech following a licensing deal in November 2023 and a subsequent acquisition agreement announced in November 2024. Clinical development includes Phase Ib/IIa monotherapy and multiple Phase II combination studies across solid tumors. Notably, the agent is also being studied in combination with BioNTech’s TROP2 antibody–drug conjugate BNT325 (DB‑1305). Importantly, DB‑1305 is a separate drug (BNT325), not a synonym for BNT327; the pair is being combined in ongoing trials. (biotheus.com)
BNT327/PM8002 is designed to simultaneously block PD‑L1 to relieve immune checkpoint inhibition and neutralize VEGF‑A to counter tumor angiogenesis. The molecule comprises a bivalent, Fc‑silenced anti‑VEGF‑A IgG1 fused to two humanized anti‑PD‑L1 single‑domain VHHs. Preclinical data show high‑affinity binding to PD‑L1 and VEGF‑A, sub‑nanomolar functional potency in PD‑1/PD‑L1 and VEGF‑A/VEGFR2 signaling assays, and antitumor activity in vivo. The design aims to concentrate VEGF blockade within PD‑L1–positive tumor microenvironments to enhance efficacy and reduce systemic VEGF‑related toxicity. (aacrjournals.org)
Basket/solid tumors (Phase Ib/IIa, monotherapy): In an update through February 3, 2023 (n=263 enrolled; 211 evaluable), overall ORR was 15.2% with a disease control rate (DCR) of 75.4% across tumor types. Signal was observed in several cohorts: cervical cancer ORR 28% (7/25), renal cell carcinoma ORR 26.9% (7/26), platinum‑resistant ovarian cancer ORR 15.4% (4/26), and EGFR‑mutant NSCLC ORR 18.5% (5/27). (ascopubs.org)
Cervical cancer and platinum‑resistant recurrent ovarian cancer (PROC) (ASCO 2024, monotherapy subset): As of December 20, 2023, among 45 evaluable cervical cancer patients, ORR was 42.2% (including 1 CR) with DCR 93.3% and median PFS 8.3 months; PD‑L1–positive (CPS ≥1) tumors had ORR 52.4% (11/21). Among 34 evaluable PROC patients, ORR was 20.6% with DCR 67.7% and median PFS 5.3 months. (ascopubs.org)
NSCLC (ASCO 2024, monotherapy): In 61 evaluable patients with advanced NSCLC, ORR and PFS varied by cohort. Treatment‑naïve cohort (n=17) had ORR 47.1% and median PFS 10.9 months; prior EGFR‑TKI cohort (n=36) had ORR 19.4% and median PFS 4.9 months; a heavily pretreated cohort (IO and platinum‑based chemotherapy) had ORR 12.5% with median PFS 6.7 months. (ascopubs.org)
IO + ADC combination rationale: Early preclinical/clinical evidence presented in 2025 supports combining BNT327/PM8002 with BNT325/DB‑1305 (TROP2 ADC) to improve efficacy without overlapping toxicities; this combination entered clinical evaluation in 2024 (part of an ongoing Phase 1/2 study). (aacrjournals.org)
Basket/solid tumors (Phase Ib/IIa, monotherapy; data to February 3, 2023): Any‑grade treatment‑related adverse events (TRAEs) occurred in 68.8% with grade ≥3 TRAEs in 18.3%. Common TRAEs included proteinuria (17.5%), hypertriglyceridemia (11.4%), elevated AST (9.9%) and ALT (9.5%), hypoalbuminemia (8.7%), and elevated GGT (6.8%). Discontinuations due to TRAEs occurred in 13.7%; no treatment‑related deaths were reported. (ascopubs.org)
NSCLC (ASCO 2024, monotherapy): Any‑grade TRAEs occurred in 85.2% with grade ≥3 in 18%. Immune‑related AEs in 37.7%; treatment‑related SAEs in 9.8%; discontinuations due to TRAEs in 8.2%. Common TRAEs (≥15%) included hypertension, hypothyroidism, proteinuria, hypoalbuminemia, hypocalcemia, and elevated AST/LDH. (ascopubs.org)
Cervical cancer and PROC (ASCO 2024, monotherapy subset): Any‑grade TRAEs in 95.4% and grade ≥3 in 35.6%; any‑grade immune‑related AEs in 57.5% (grade ≥3 in 8%). Discontinuations due to TRAEs in 14.9%. Proteinuria, hypertension, anemia, elevated WBC count, and thrombocytosis were among the most common events. (ascopubs.org)
Notes: Clinical outcomes above are from meeting abstracts (interim data) and may evolve with ongoing follow‑up and subsequent publications.
Last updated: Oct 2025
Goal: To compare the safety and antitumor activity of pumitamig plus first-line chemotherapy versus bevacizumab plus first-line chemotherapy in unresectable or metastatic colorectal cancer, and to select a pumitamig dose for the phase 3 portion.
Patients: Adults with previously untreated, histologically confirmed recurrent/metastatic colorectal adenocarcinoma that is unresectable/not amenable to curative surgery and has measurable disease by RECIST v1.1. Tumors must be microsatellite stable/mismatch repair proficient by historical testing (no known dMMR/MSI-H) and must not have a known BRAF V600E mutation by local testing. Key exclusions include untreated CNS metastases, active malignancy within 2 years (with limited exceptions), significant recent cardiovascular/thrombotic disease or uncontrolled hypertension, and any prior systemic anticancer therapy for advanced disease including prior immune checkpoint-directed therapy.
Design: Blinded, randomized, multicenter phase 2/3 study with a dose-finding/selection phase 2 component followed by a confirmatory phase 3 comparison. Participants are randomized to pumitamig-chemotherapy or bevacizumab-chemotherapy regimens, with disease assessments using RECIST v1.1; the phase 3 primary efficacy assessment uses blinded independent central review for PFS.
Treatments: Experimental therapy is pumitamig (BNT327/PM8002) in combination with standard doublet chemotherapy (FOLFOX or FOLFIRI, with CAPOX included in some arms). Pumitamig is an investigational bispecific antibody targeting PD-L1 and VEGF-A, combining checkpoint blockade with anti-angiogenic inhibition to enhance antitumor immunity and modulate tumor vasculature. Early-phase studies in other tumor types have reported high objective response rates when combined with chemotherapy (for example, approximately 55% in EGFR-mutant NSCLC after TKI and >80% in extensive-stage SCLC in initial reports) with a manageable safety profile that includes expected chemotherapy cytopenias and immune-related adverse events. The control therapy is bevacizumab combined with investigator-chosen chemotherapy (FOLFOX or FOLFIRI, with CAPOX included in some arms); bevacizumab is an anti-VEGF-A monoclonal antibody widely used with fluoropyrimidine/oxaliplatin- or irinotecan-based regimens in first-line metastatic colorectal cancer.
Outcomes: Phase 2 primary endpoint is confirmed objective response rate (CR+PR) by investigator-assessed RECIST v1.1, with phase 2 secondary endpoints including investigator-assessed PFS, duration of response, time to response, disease control rate, and selection of the recommended pumitamig dose for phase 3. Phase 3 primary endpoint is progression-free survival by RECIST v1.1 assessed by blinded independent central review. Key phase 3 secondary endpoints include overall survival, objective response rate by central review, and duration of response by central review. Outcomes are followed for up to 5 years.
Burden on patient: Moderate burden. Treatment involves standard-of-care intravenous chemotherapy backbones with an added intravenous biologic (pumitamig or bevacizumab), requiring regular infusion visits and routine laboratory monitoring typical for FOLFOX/FOLFIRI/CAPOX-based care. Imaging will be performed repeatedly for RECIST-based response and PFS assessment over long-term follow-up, and the blinded design with central review may increase scheduling rigor for scans compared with routine practice. No explicit requirement for mandatory biopsies or intensive pharmacokinetic sampling is provided in the available description, suggesting the additional burden beyond standard first-line metastatic CRC management is mainly related to study visit structure, randomization, and protocol-driven assessment timing.
Last updated: Jan 2026
Inclusion Criteria
* Participant must previously untreated, histologically confirmed recurrent or metastatic colorectal adenocarcinoma, not amenable to curative surgery.
* Participant must have no known presence of mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer (CRC) per historical results (a validated test should be used).
* Participant must have no known presence of the gene that encodes the protein B-Raf (BRAF) V600E mutation per local testing.
* Participant must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
Exclusion Criteria
* Participant must not have any untreated known central nervous system (CNS) metastases including brain, leptomeningeal and/or spinal cord compression.
* Participant must not have any prior malignancy active within the previous 2 years, except for locally curable cancers that have been apparently cured and considered to be of low risk of recurrence.
* Participant must not have significant cardiovascular disease, such as myocardial infarction, unstable angina, arterial thrombosis or cerebrovascular accident within 6 months prior to randomization, uncontrolled hypertension (≥ 160 systolic, ≥ 100 diastolic mm Hg) despite optimal medical management, or congenital long QT syndrome.
* Participant must not have prior systemic treatment with an anti-PD-1, anti-programmed death (ligand)-1 (PD-L1), anti-PD-L2, CD137 agonists, or anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) antibody, or any other antibody or drug specifically targeting T cell co-stimulation or checkpoint pathways or chemotherapy.
* Other protocol-defined Inclusion/Exclusion criteria apply.
Nashville, Tennessee, 37203, United States
No email / 615-986-4366
Status: Recruiting
Arlington, Texas, 76012, United States
No email / No phone
Status: Recruiting
Austin, Texas, 78705, United States
No email / 512-427-9400
Status: Recruiting
Seoul, Seoul Teugbyeolsi, 03080, South Korea
No email / No phone
Status: Active, not recruiting
Buenos Aires, C1426ANZ, Argentina
No email / No phone
Status: Not yet recruiting
Buenos Aires, C1280AEB, Argentina
No email / No phone
Status: Not yet recruiting
Buenos Aires, C1431FWO, Argentina
No email / No phone
Status: Not yet recruiting
Buenos Aires, 1039, Argentina
No email / No phone
Status: Not yet recruiting
ABB, Buenos Aires F.D., C1199ABB, Argentina
No email / No phone
Status: Not yet recruiting
Wentworthville, NSW2145, Australia
No email / No phone
Status: Not yet recruiting
Malvern, 3144, Australia
No email / No phone
Status: Not yet recruiting
St Leonards, New South Wales, 2065, Australia
No email / No phone
Status: Not yet recruiting
Liverpool, New South Wales, 2170, Australia
No email / No phone
Status: Not yet recruiting
Woolloongabba, Queensland, 4102, Australia
No email / No phone
Status: Not yet recruiting
Herston, Queensland, 4029, Australia
No email / No phone
Status: Not yet recruiting
Birtinya, Queensland, 4575, Australia
No email / No phone
Status: Not yet recruiting
Elizabeth Vale, South Australia, 05112, Australia
No email / No phone
Status: Not yet recruiting
Adelaide, South Australia, 5042, Australia
No email / No phone
Status: Not yet recruiting
Epping, Victoria, 3076, Australia
No email / No phone
Status: Not yet recruiting
Shepparton, Victoria, 3630, Australia
No email / No phone
Status: Not yet recruiting
Ballarat, Victoria, 3350, Australia
No email / No phone
Status: Not yet recruiting
St Albans, Victoria, 3021, Australia
No email / No phone
Status: Not yet recruiting
Perth, Western Australia, 6150, Australia
No email / No phone
Status: Not yet recruiting
Linz, 4010, Austria
No email / No phone
Status: Not yet recruiting
Vienna, A-1090, Austria
No email / No phone
Status: Not yet recruiting
Salzburg, 5020, Austria
No email / No phone
Status: Not yet recruiting
Leuven, 3000, Belgium
No email / No phone
Status: Not yet recruiting
Brussels, 1000, Belgium
No email / No phone
Status: Not yet recruiting
Edegem, Antwerpen, 2650, Belgium
No email / No phone
Status: Not yet recruiting
Brussels, MO, 1200, Belgium
No email / No phone
Status: Not yet recruiting
Roeselare, West-Vlaanderen, 8800, Belgium
No email / No phone
Status: Not yet recruiting
São Paulo, 01246-000, Brazil
No email / No phone
Status: Not yet recruiting
São Paulo, 01308-060, Brazil
No email / No phone
Status: Not yet recruiting
Curitiba, Paraná, 81480-580, Brazil
No email / No phone
Status: Not yet recruiting
Natal/RN, Rio Grande do Norte, 59062-000, Brazil
No email / No phone
Status: Not yet recruiting
Porto Alegre, Rio Grande do Sul, 91610-000, Brazil
No email / No phone
Status: Not yet recruiting
Santa Cruz do Sul, Rio Grande do Sul, 96810-110, Brazil
No email / No phone
Status: Not yet recruiting
Barretos, São Paulo, 14784400, Brazil
No email / No phone
Status: Not yet recruiting
Calgary, Alberta, T2N 5G2, Canada
No email / No phone
Status: Not yet recruiting
Halifax, Nova Scotia, B3H 3A7, Canada
No email / No phone
Status: Not yet recruiting
Ottawa, Ontario, K1H 8L6, Canada
No email / No phone
Status: Not yet recruiting
Toronto, Ontario, M5G 2M9, Canada
No email / No phone
Status: Not yet recruiting
Montreal, Quebec, H2X 3E4, Canada
No email / No phone
Status: Not yet recruiting
Montreal, Quebec, H3T 1E2, Canada
No email / No phone
Status: Not yet recruiting
Santiago, Santiago Metropolitan, 7620002, Chile
No email / No phone
Status: Not yet recruiting
Santiago, Santiago Metropolitan, 7620002, Chile
No email / No phone
Status: Not yet recruiting
Santiago, Santiago Metropolitan, 7500921, Chile
No email / No phone
Status: Not yet recruiting
Shanghai, 200032, China
No email / No phone
Status: Not yet recruiting
Hangzhou, 310009, China
No email / No phone
Status: Not yet recruiting
Fuzhou, Fujian, 350014, China
No email / No phone
Status: Not yet recruiting
Fuzhou Fujian, Fujian, 350001, China
No email / No phone
Status: Not yet recruiting
Guangzhou, Guangdong, 510555, China
No email / No phone
Status: Not yet recruiting
Harbin, Heilongjiang, 150081, China
No email / No phone
Status: Not yet recruiting
Changsha, Hunan, 410031, China
No email / No phone
Status: Not yet recruiting
Shenyang, Liaoning, 110042, China
No email / No phone
Status: Not yet recruiting
Shanghai, Shanghai Municipality, 200120, China
No email / No phone
Status: Not yet recruiting
Hangzhou, Zhejiang, 310003, China
No email / No phone
Status: Not yet recruiting
Brno, 656 53, Czechia
No email / No phone
Status: Not yet recruiting
Hradec Králové, 500 05, Czechia
No email / No phone
Status: Not yet recruiting
Prague, Praha 5, 150 06, Czechia
No email / No phone
Status: Not yet recruiting
Prague, Praha, Hlavní Mesto, 12808, Czechia
No email / No phone
Status: Not yet recruiting
Toulose, 31059, France
No email / No phone
Status: Not yet recruiting
Villejuif, 94805, France
No email / No phone
Status: Not yet recruiting
Rouen, 76000, France
No email / No phone
Status: Not yet recruiting
Dijon, 21000, France
No email / No phone
Status: Not yet recruiting
Pessac, 33064, France
No email / No phone
Status: Not yet recruiting
Paris, 75012, France
No email / No phone
Status: Not yet recruiting
Saint-Herblain, Loire-Atlantique, 44805, France
No email / No phone
Status: Not yet recruiting
Marseille, Provence-Alpes-Côte d'Azur Region, 13273, France
No email / No phone
Status: Not yet recruiting
München, 81737, Germany
No email / No phone
Status: Not yet recruiting
Berlin, 10117, Germany
No email / No phone
Status: Not yet recruiting
Ulm, 89081, Germany
No email / No phone
Status: Not yet recruiting
Hamburg, 20249, Germany
No email / No phone
Status: Not yet recruiting
Frankfurt, 60488, Germany
No email / No phone
Status: Not yet recruiting
Leipzig, D-04103, Germany
No email / No phone
Status: Not yet recruiting
Düsseldorf, 40479, Germany
No email / No phone
Status: Not yet recruiting
Göttingen, 37075, Germany
No email / No phone
Status: Not yet recruiting
Mannheim, 68167, Germany
No email / No phone
Status: Not yet recruiting
Mainz, 55131, Germany
No email / No phone
Status: Not yet recruiting
Bochum, 44791, Germany
No email / No phone
Status: Not yet recruiting
Dresden, Saxony, 01307, Germany
No email / No phone
Status: Not yet recruiting
Delhi, 110029, India
No email / No phone
Status: Not yet recruiting
Pune, 411001, India
No email / No phone
Status: Not yet recruiting
Delhi, 110029, India
No email / No phone
Status: Not yet recruiting
Puducherry, 605006, India
No email / No phone
Status: Not yet recruiting
Nashik, Dādra and Nagar Haveli and Damān and Diu, 422001, India
No email / No phone
Status: Not yet recruiting
Mumbai, Maharashtra, 400012, India
No email / No phone
Status: Not yet recruiting
Mumbai, Maharashtra, 400036, India
No email / No phone
Status: Not yet recruiting
Milan, 20133, Italy
No email / No phone
Status: Not yet recruiting
Padua, 35128, Italy
No email / No phone
Status: Not yet recruiting
Pisa, 56126, Italy
No email / No phone
Status: Not yet recruiting
Catania, 95124, Italy
No email / No phone
Status: Not yet recruiting
Reggio Emilia, 42123, Italy
No email / No phone
Status: Not yet recruiting
Napoli, 80131, Italy
No email / No phone
Status: Not yet recruiting
San Giovanni Rotondo, Foggia, 71013, Italy
No email / No phone
Status: Not yet recruiting
Milan, Milano, 20162, Italy
No email / No phone
Status: Not yet recruiting
Fukuoka, 811-1395, Japan
No email / No phone
Status: Not yet recruiting
Sunto-gun, 411-8777, Japan
No email / No phone
Status: Not yet recruiting
Sendai, 980-8574, Japan
No email / No phone
Status: Not yet recruiting
Chikusa-ku, 464-8681, Japan
No email / No phone
Status: Not yet recruiting
Kashiwa, 277-8577, Japan
No email / No phone
Status: Not yet recruiting
Osaka, 541-8567, Japan
No email / No phone
Status: Not yet recruiting
Chiba, Chiba, 260-8717, Japan
No email / No phone
Status: Not yet recruiting
Matsuyama, Ehime, 791-0280, Japan
No email / No phone
Status: Not yet recruiting
Sapporo, Hokkaido, 0608648, Japan
No email / No phone
Status: Not yet recruiting
Kobe, Hyōgo, 6500047, Japan
No email / No phone
Status: Not yet recruiting
Yokohama, Kanagawa, 2418515, Japan
No email / No phone
Status: Not yet recruiting
Suita, Osaka, 565-0871, Japan
No email / No phone
Status: Not yet recruiting
Takatsuki, Osaka, 569-8686, Japan
No email / No phone
Status: Not yet recruiting
Hidaka, Saitama, 350-1298, Japan
No email / No phone
Status: Not yet recruiting
Koto-ku, Tokyo, 1358550, Japan
No email / No phone
Status: Not yet recruiting
Chuo-ku, Tokyo, 104-0045, Japan
No email / No phone
Status: Not yet recruiting
Utrecht, 3543 AZ, Netherlands
No email / No phone
Status: Not yet recruiting
Groningen, 9713 GZ, Netherlands
No email / No phone
Status: Not yet recruiting
Tilburg, 5022 GC, Netherlands
No email / No phone
Status: Not yet recruiting
Amsterdam, North Holland, 1105 AZ, Netherlands
No email / No phone
Status: Not yet recruiting
Opole, 45-372, Poland
No email / No phone
Status: Not yet recruiting
Krakow, Lesser Poland Voivodeship, 31-826, Poland
No email / No phone
Status: Not yet recruiting
Jelenia Góra, Lower Silesian Voivodeship, 58-506, Poland
No email / No phone
Status: Not yet recruiting
Warsaw, Masovian Voivodeship, 03-411, Poland
No email / No phone
Status: Not yet recruiting
Warsaw, Masovian Voivodeship, 01-748, Poland
No email / No phone
Status: Not yet recruiting
Warsaw, Masovian Voivodeship, 02-507, Poland
No email / No phone
Status: Not yet recruiting
Gliwice, Silesian Voivodeship, 44-101, Poland
No email / No phone
Status: Not yet recruiting
Bucharest, 22328, Romania
No email / No phone
Status: Not yet recruiting
Cluj-Napoca, 400015, Romania
No email / No phone
Status: Not yet recruiting
Iași, 700483, Romania
No email / No phone
Status: Not yet recruiting
Craiova, 200347, Romania
No email / No phone
Status: Not yet recruiting
Iași, 700106, Romania
No email / No phone
Status: Not yet recruiting
Cluj-Napoca, Cluj, 400162, Romania
No email / No phone
Status: Not yet recruiting
Singapore, 119074, Singapore
No email / No phone
Status: Not yet recruiting
Singapore, 308442, Singapore
No email / No phone
Status: Not yet recruiting
Singapore, 329563, Singapore
No email / No phone
Status: Not yet recruiting
Singapore, Central Singapore, 168583, Singapore
No email / No phone
Status: Not yet recruiting
Seoul, 120-752, South Korea
No email / No phone
Status: Not yet recruiting
Seoul, 05505, South Korea
No email / No phone
Status: Not yet recruiting
Seongnam, Gyeonggido, 13620, South Korea
No email / No phone
Status: Not yet recruiting
Seoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea
No email / No phone
Status: Not yet recruiting
Seoul, Seoul-teukbyeolsi [Seoul], 06591, South Korea
No email / No phone
Status: Not yet recruiting
Madrid, 28007, Spain
No email / No phone
Status: Not yet recruiting
Málaga, 29011, Spain
No email / No phone
Status: Not yet recruiting
Seville, 41013, Spain
No email / No phone
Status: Not yet recruiting
Badalona, Barcelona [Barcelona], 08916, Spain
No email / No phone
Status: Not yet recruiting
Barcelona, Barcelona [Barcelona], 08035, Spain
No email / No phone
Status: Not yet recruiting
Madrid, Madrid, Comunidad de, 28041, Spain
No email / No phone
Status: Not yet recruiting
Pamplona, Navarre, 31009, Spain
No email / No phone
Status: Not yet recruiting
Lund, 22184, Sweden
No email / No phone
Status: Not yet recruiting
Stockholm, Stockholm County, 17176, Sweden
No email / No phone
Status: Not yet recruiting
Gothenburg, Västra Götaland County, 41685, Sweden
No email / No phone
Status: Not yet recruiting
Kaohsiung City, 807, Taiwan
No email / No phone
Status: Not yet recruiting
Tainan, Taiana, 704, Taiwan
No email / No phone
Status: Not yet recruiting
Taipei, 100229, Taiwan
No email / No phone
Status: Not yet recruiting
Taipei, 112, Taiwan
No email / No phone
Status: Not yet recruiting
Taoyuan District, 333, Taiwan
No email / No phone
Status: Not yet recruiting
Kaohsiung Niao Sung Dist, Kaohsiung, 83301, Taiwan
No email / No phone
Status: Not yet recruiting
Erzurum, 25070, Turkey (Türkiye)
No email / No phone
Status: Not yet recruiting
Adana, 1370, Turkey (Türkiye)
No email / No phone
Status: Not yet recruiting
Ankara, 06100, Turkey (Türkiye)
No email / No phone
Status: Not yet recruiting
Kadiköy/Istanbul, 41380, Turkey (Türkiye)
No email / No phone
Status: Not yet recruiting
Istanbul, 34214, Turkey (Türkiye)
No email / No phone
Status: Not yet recruiting
Glasgow, G12 0YN, United Kingdom
No email / No phone
Status: Not yet recruiting
Sutton, SM2 5PT, United Kingdom
No email / No phone
Status: Not yet recruiting
Kent, ME16 9QQ, United Kingdom
No email / No phone
Status: Not yet recruiting
London, SM2 5PT, United Kingdom
No email / No phone
Status: Not yet recruiting
Manchester, Lancashire, M20 4BX, United Kingdom
No email / No phone
Status: Not yet recruiting
Los Angeles, California, 90033, United States
No email / No phone
Status: Not yet recruiting
Stanford, California, 94305, United States
No email / No phone
Status: Not yet recruiting
San Francisco, California, 94115, United States
No email / No phone
Status: Not yet recruiting
Santa Monica, California, 90404, United States
No email / No phone
Status: Not yet recruiting
Orange, California, 92868, United States
No email / No phone
Status: Not yet recruiting
Tampa, Florida, 33612, United States
No email / No phone
Status: Not yet recruiting
Cape Coral, Florida, 33990, United States
No email / No phone
Status: Not yet recruiting
St. Petersburg, Florida, 33705, United States
No email / No phone
Status: Not yet recruiting
Duluth, Georgia, 30096, United States
No email / No phone
Status: Not yet recruiting
Marietta, Georgia, 30060, United States
No email / No phone
Status: Not yet recruiting
Chicago, Illinois, 60637, United States
No email / No phone
Status: Not yet recruiting
Iowa City, Iowa, 52242, United States
No email / No phone
Status: Not yet recruiting
Baltimore, Maryland, 21287, United States
No email / No phone
Status: Not yet recruiting
Silver Spring, Maryland, 20904, United States
No email / No phone
Status: Not yet recruiting
Boston, Massachusetts, 02114, United States
No email / No phone
Status: Not yet recruiting
Grand Rapids, Michigan, 49546, United States
No email / No phone
Status: Not yet recruiting
Ann Arbor, Michigan, 48109, United States
No email / No phone
Status: Not yet recruiting
Maple Grove, Minnesota, 55369, United States
No email / No phone
Status: Not yet recruiting
Kansas City, Missouri, 64111, United States
No email / No phone
Status: Not yet recruiting
St Louis, Missouri, 63110, United States
No email / No phone
Status: Not yet recruiting
Omaha, Nebraska, 68198, United States
No email / No phone
Status: Not yet recruiting
Mineola, New York, 11501-389, United States
No email / No phone
Status: Not yet recruiting
Buffalo, New York, 14263, United States
No email / No phone
Status: Not yet recruiting
Lake Success, New York, 11042, United States
No email / No phone
Status: Not yet recruiting
Fargo, North Dakota, 58102, United States
No email / No phone
Status: Not yet recruiting
Columbus, Ohio, 43210, United States
No email / No phone
Status: Not yet recruiting
Portland, Oregon, 97239, United States
No email / No phone
Status: Not yet recruiting
Pittsburgh, Pennsylvania, 15212, United States
No email / No phone
Status: Not yet recruiting
Allentown, Pennsylvania, 18103, United States
No email / No phone
Status: Not yet recruiting
Sioux Falls, South Dakota, 57104, United States
No email / No phone
Status: Not yet recruiting
Nashville, Tennessee, 37203, United States
No email / No phone
Status: Not yet recruiting
Houston, Texas, 77030, United States
No email / No phone
Status: Not yet recruiting
Longview, Texas, 75702, United States
No email / No phone
Status: Not yet recruiting
Salt Lake City, Utah, 84102, United States
No email / No phone
Status: Not yet recruiting
Fairfax, Virginia, 22031, United States
No email / No phone
Status: Not yet recruiting
Norfolk, Virginia, 23502, United States
No email / No phone
Status: Not yet recruiting
Seattle, Washington, 98109, United States
No email / No phone
Status: Not yet recruiting
Edmonds, Washington, 98026-8032, United States
No email / No phone
Status: Not yet recruiting
Vancouver, Washington, 98684, United States
No email / No phone
Status: Not yet recruiting